Earnings Call for Q2FY22 of Relaxo Footwears
Conference Call with Relaxo Footwears Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.10-11-2021
10-11-2021
Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Unaudited financial results for the quarter and half year ended on 30th September, 202109-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investors call (Q2 FY 22 Post Result Conference Call) of Relaxo Footwears Limited will be held on Tuesday, 9th November, 2021, at 04:00 PM (IST).03-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Un-Audited Financial Results for the quarter and half year ended on September 30, 202102-11-2021
Relaxo Footwears Ltd - 530517 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation of grant of 358000 options pursuant to RFL ESOP Plan 2014 and allotment of 483945 equity shares pursuant to RFL ESOP Plan, 201402-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Intimation For Commissioning Of Unit At Bhiwadi Rajasthan
Intimation for commissioning of Unit at Bhiwadi Rajasthan and enhancement of capacity.02-11-2021
Q2FY22 Quarterly Result Announced for Relaxo Footwears Ltd.
Highlights for Q2 FY22: Q2 FY22 Revenue at Rs. 714 crore grew strongly at 24%YoY Q2 FY22 EBITDA stood at Rs. 117 crore; Margins at 16.4% Q2 FY22 Profit After Tax stood at Rs. 69 crore; Margins at 9.6% Other income stood at Rs. 7 crore as compared to Rs. 5 crore in the corresponding period of the previous year. The increase is mainly due to higher interest income on investments during the quarter. Highlights for H1 FY22: Revenue at Rs. 1,212 crore as compared to Rs. 939 crore in the corresponding period of the previous year. EBITDA at Rs. 183 crore as compared to Rs. 184 crore in the corresponding period of the previous year. Profit after Tax at Rs. 100 crore as compared to Rs. 99 crore in the corresponding period of the previous year. Commenting on the results and performance, Mr. Ramesh Kumar Dua, Managing Director said: “During the quarter it was heartening to see the way our country came out of the grip of second wave of COVID 19 and how the economy returned back to normalcy. It is remarkable that India is able to administer more than 100 crore of COVID 19 vaccine dosages and with this the medium term outlook seems quite promising specially for consumer facing business like us. Relaxo registered good growth in revenue on the back of demand recovery due to opening of the stores across geographies, strong rebound in economic activities resulting in business returning to pre-covid levels. Inflationary trend in the raw material prices has further intensified and has reached elevated levels which impacted gross margins. However, we have concern about the increasing trend in raw material prices and taking all possible measures to mitigate its impact on margins including timely price increase. We are firmly and resolutely on a journey to accelerate our growth further by using a diverse portfolio, enhanced distribution network & deployment of resources in innovation, brand promotion and continuing to follow customer centric approach.” Result PDF02-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on unaudited financial results for the quarter and half year ended on 30th September, 2021.01-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Unaudited Financial Results For The Quarter And Year Ended On 30-09-2021
Unaudited financial results for the quarter and year ended on 30-09-202101-11-2021
RELAXO FOOTWEARS LTD.-$ - 530517 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, 1St Day Of November, 2021 Inter-Alia To Consider, Review, Approve And Take On Record Un-Audited Financial Results For The Quarter And Half Year Ended On September 30, 2021.
RELAXO FOOTWEARS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2021 ,inter alia, to consider and approve Intimation of Board Meeting to be held on Monday, 1st day of November, 2021 inter-alia to consider, review, approve and take on record Un-Audited Financial Results for the quarter and half year ended on September 30, 2021.20-10-2021